DRUG DISCOVERY - History of Changes


DateDescription
2023-05-29 delete email la..@umich.edu
2023-05-29 delete person Bruce Mueller
2023-05-29 delete person Judith S. Leopold
2023-05-29 insert email ls..@umich.edu
2023-05-29 insert person Jolanta Grembecka
2022-12-07 delete person Traci Swan Rowe
2022-12-07 insert person Megan M. Connolly
2022-11-06 update person_description Leah Makley => Dr. Leah Makley
2022-11-06 update person_description Lawrence G. Hamann => Lawrence G. Hamann
2022-11-06 update person_title Dr. Leah Makley: President and CEO, ViewPoint Therapeutics U - M PhD ( '14 ) Medicinal Chemistry University of Dayton BS ( '09 ) Biochemistry => COO, Deciduous Therapeutics U - M PhD ( '14 ) Medicinal Chemistry University of Dayton BS ( '09 ) Biochemistry; COO of Deciduous Therapeutics
2022-11-06 update person_title Lawrence G. Hamann: Head of Drug Discovery, Takeda U - M PhD ( '91 ) Organic Chemistry University of Detroit BS ( '86 ) Chemistry => Co - Founder, President and CEO of Interdict; Co - Founder, President, CEO, Interdict Bio U - M PhD ( '91 ) Organic Chemistry University of Detroit BS ( '86 ) Chemistry
2022-09-05 delete person Mindy Mackey
2022-09-05 delete person Pil Lee
2022-06-06 delete person Ed Pagani
2022-06-06 update person_description Bruce Leuchter => Bruce Leuchter
2022-06-06 update person_title Bruce Leuchter: Partner, PJT Partners Wayne State University MD ( '00 ) U - M BA ( '96 ); Partner => President and CEO, Neurvati Wayne State University MD ( '00 ) U - M BA ( '96 )
2022-03-07 delete person Robert B Sweet
2022-03-07 insert person Jonathan Sexton
2021-12-12 insert partner_pages_linkeddomain innovationpartnerships.umich.edu
2021-08-17 insert person Traci Swan Rowe
2021-06-11 delete person Rachel L. Wallace
2021-06-11 insert address Mary Sue Coleman Hall 210 Washtenaw Avenue, Rm. 4403 Ann Arbor, MI 48109-2216